Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Methamphetamine (MA) abuse leads to significant neurotoxicity, particularly affecting dopaminergic pathways.
• Protein kinase C (PKC) isozymes are implicated in cellular signaling and stress responses, but their specific roles in MA neurotoxicity remain unclear.

Purpose of the Study:

• To investigate the involvement of specific PKC isozymes in the mechanisms underlying methamphetamine-induced dopaminergic toxicity.
• To determine if inhibiting PKC isozymes can mitigate MA-induced neurotoxic effects.

Main Methods:

• Administered multiple doses of MA to rodents and assessed behavioral impairments, PKC isozyme expression, oxidative stress markers, apoptosis, and dopaminergic markers (dopamine turnover, tyrosine hydroxylase, DAT, VMAT2).
• Utilized specific PKC inhibitors (Gö6976, hispidin, rottlerin, PKCζ pseudosubstrate inhibitor) and PKCδ knockout mice to evaluate the role of individual PKC isozymes.
• Quantified lipid peroxidation, protein oxidation, and apoptosis using biochemical assays and TUNEL staining.

Main Results:

• MA significantly increased PKCδ expression but did not alter PKCα, PKCβI, PKCβII, or PKCζ expression.
• Inhibition of PKCδ with rottlerin dose-dependently attenuated MA-induced behavioral impairments, oxidative stress, and apoptosis.
• PKCδ knockout mice exhibited no significant MA-induced behavioral impairments or dopaminergic damage.
• PKCδ inhibition prevented MA-induced alterations in dopamine turnover, tyrosine hydroxylase activity, and the expression of TH, DAT, and VMAT2.

Conclusions:

• PKCδ is a critical mediator of methamphetamine-induced oxidative stress and dopaminergic neurotoxicity.
• Targeting PKCδ, for example, through pharmacological inhibition, represents a promising therapeutic strategy for preventing MA-induced neurotoxicity.